Efficacy of the Consumption of a Spinach Extract on Muscle Function in Subjects Over 50 Years of Age

NCT ID: NCT04612127

Last Updated: 2021-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-14

Study Completion Date

2021-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Controlled, randomized, single-center, double-blind clinical trial, with two parallel branches depending on the product consumed, to measure the efficacy of a supplement extracted from spinach on muscle strength in subjects over 50 years of age.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects who meet the selection criteria will make two visits to the laboratory to perform the tests established in the protocol. In addition, all subjects will develop a program of strength, polyarticular, individualized and progressive exercises in which the main muscle groups are worked. The program will be held three days a week (36 sessions). Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Physical Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group - Spinach

Consumption for 90 days of spinach extract (1000mg)

Four capsules will be consumed per day, two with breakfast and two with lunch.

Group Type EXPERIMENTAL

Dietary supplement consumption and physical exercise

Intervention Type DIETARY_SUPPLEMENT

The consumption time of the experimental product was 90 days and the control consumption time was 90 days.

During this time, training should be done three times a week.

control group Placebo (sucrose)

Four capsules will be consumed per day, two with breakfast and two with lunch.

Group Type PLACEBO_COMPARATOR

Dietary supplement consumption and physical exercise

Intervention Type DIETARY_SUPPLEMENT

The consumption time of the experimental product was 90 days and the control consumption time was 90 days.

During this time, training should be done three times a week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary supplement consumption and physical exercise

The consumption time of the experimental product was 90 days and the control consumption time was 90 days.

During this time, training should be done three times a week.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 50 and 75 years.
* Body mass index less than 32.
* Subjects who do not develop physical exercise scheduled on a weekly basis.
* Subjects who have given written informed consent to participate in the study.

Exclusion Criteria

* Consumption during the 6 months prior to the study of functional food or supplement that modifies body composition.
* Presence of absolute or relative contraindications dictated by the American College of Sports Medicine, for the performance of physical exercise.
* Presence of chronic diseases that prevent the performance of a physical exercise program (disabling arthropathies, moderate / severe chronic lung disease, ischemic heart disease under treatment, arrhythmias, etc.).
* Abuse in the ingestion of alcohol.
* Present hypersensitivity or intolerance to any of the components of the products under study.
* Inability to understand informed consent.
* Serious or terminal illnesses.
* Subjects with a body mass index above 32.
* Pregnant or lactating women.
* Inability to understand informed consent.
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Católica San Antonio de Murcia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco Javier López Román

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Catholic University of Murcia

Murcia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UCAMCFE-00016

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Middle Age muScle Krill Study
NCT06005064 RECRUITING NA
Mushroom Blend on Oxygen Kinetics
NCT02075892 COMPLETED NA